The above suggest the collaboration of a side effect of radiotherapy (i.e. premature senescence) with invasive tumor cells that leads to the upregulation of SDC1, a poor prognostic factor; in addition these data further support the role of TGF-β in breast tumor growth. Here, TGFB1 is linked to neoplasm.